Mon, April 20, 2020

Adam Walsh Maintained (ASND) at Strong Buy with Increased Target to $171 on, Apr 20th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-171-on-apr-20th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Adam Walsh of Stifel, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Increased Target from $146 to $171 on, Apr 20th, 2020.

Adam has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Adam's Rating of Hold.



This is the rating of the analyst that currently disagrees with Adam


  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $180 on, Thursday, April 2nd, 2020